Retrieved January 16, 2025
McCullough KD, Martindale JL, Klotz LO, Aw TY, Holbrook NJ
Diabetes 58 , 22582266 (2009)
Final Thoughts GLP-1 medications can be powerful tools for improving health
That said, understanding the difference between supplement-level support and prescription-level clinical outcomes is important for setting realistic expectations
4 In contrast, Eli Lillys upcoming oral GLP1 candidate, orforglipron, is a smallmolecule drug rather than a peptide, which could lessen the need for dosing requirements and offer greater convenience to users